Akèy › Poliradikiloneyropati demyelinizan enflamatwa kwonik › Pennsylvania
Etid klinik pou Poliradikiloneyropati demyelinizan enflamatwa kwonik nan Pennsylvania
6 etid pou Poliradikiloneyropati demyelinizan enflamatwa kwonik ap chèche patisipan nan sit nan Pennsylvania.
Vil nan Pennsylvania
Tèks ofisyèl etid la (Anglè)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1616, Philadelphia
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07032662A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Penn Medicine University City, Philadelphia
- Jefferson Health Honickman Center, Philadelphia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07091630A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Perelman Center for Advanced Medicine, Philadelphia
- Jefferson Health Honickman Center, Philadelphia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06920004A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Penn State Health Milton South Hershey Medical Center- Site Number : 8400042, Hershey
- Penn Medicine: University of Pennsylvania Health System- Site Number : 8400022, Philadelphia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06290141Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
- Investigational Site, Swiftwater
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06968975A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Penn Blood Disorders Program - Hospital of The University of Pennsylvania, Philadelphia
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT06798012Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.